rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

MultiSensor AI Holdings, Inc.

MSAI · Nasdaq

Health CareLife-science toolsNot moving yet

MSAI stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 28.4% below that average now. Life Science Tools & Research Services: 54% of its 79 stocks in an uptrend (+4 points in four weeks); Health Care: 26% (−10 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 52
Industry in uptrend
54% +4 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
9 (-8)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.

20 Apr – 19 Oct
27%44%61%Apr 26Jun 26Jul 26Sep 26Oct 26

Life-science tools: About half its stocks are in an uptrend and the share has been climbing. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$140K$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders9-8 on the quarter
New · exited2 · 10
Reported value$3.8M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
325 CAPITAL LLCreduced · filed 14 Aug 2026662,244$3.5M-25,827,668−97.5%
Bleichroeder LPreduced · filed 13 Aug 202630,562$159K-1,191,931−97.5%
VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 202621,622$113K-843,309−97.5%
VANGUARD FIDUCIARY TRUST COreduced · filed 13 Aug 20265,870$31K-228,932−97.5%
Tower Research Capital LLC (TRC)new · filed 11 Aug 20261,756$9,149+1,756
BARCLAYS PLCnew · filed 14 Aug 20261,751$9,123+1,751
UBS Group AGreduced · filed 13 Aug 20261,316$6,856-44,164−97.1%
SBI Securities Co., Ltd.reduced · filed 23 Jul 2026265$1,381-35,349−99.3%
CHILTON CAPITAL MANAGEMENT LLCreduced · filed 4 Aug 2026187$975-7,313−97.5%
31 Dec 2023 – 30 Jun 2026
31220Dec 23Sep 24Mar 25Dec 25Jun 26

Everyone who traded it

Daniel M. Friedberg Company insiderDirector, 10% owner, Other · last 30 Sep 20260 · 0
David Gow Company insiderDirector · last 30 Sep 20260 · 0
Margaret M. Chu Company insiderDirector · last 30 Sep 20260 · 0
Petros Kitsos Company insiderDirector · last 30 Sep 20260 · 0
Stuart Flavin V Company insiderDirector · last 30 Sep 20260 · 0
Asim Akram Company insiderChief Executive Officer · last 16 Jul 20260 · 0
Robert Nadolny Company insiderChief Financial Officer · last 16 Jul 20260 · 0
325 Capital Master Fund Lp Company insider10% owner, Other · last 31 Mar 20260 · 0
Anil K. Shrivastava Company insider10% owner, Other · last 19 Dec 20250 · 0
325 CAPITAL LLC Company insider10% owner, Other · last 24 Oct 20250 · 0
Gary Eugene Strahan Company insider10% owner · last 28 Jul 20250 · 12
325 Capital Gp, Llc Company insiderOther · last 30 Jun 20250 · 0

Same industry

OABI OmniAbLeading+67%
TXG 10x GenomicsLeading+59%
AVTR AvantorLeading+45%
ILMN IlluminaLeading+44%
RVTY RevvityLeading+35%
MASS 908 DevicesLeading+32%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Operating profit marginFY 2025 · to 31 Dec 2025-216%
Free cash flow marginFY 2025 · to 31 Dec 2025-174%
Return on capital employedFY 2025 · to 31 Dec 2025-36.6%
Share count trendFY 2025 · to 9 Mar 20260.2%
Cash and equivalentsFY 2025 · to 31 Dec 2025$24.4M
Free cash flowFY 2025 · to 31 Dec 2025−$9.7M

Analyst forecasts

No analyst forecasts yet.